JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263299

Human PLA2G12A (Phospholipase A2 XII) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

PLA2G12A KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon1.
1 Images
Sanger Sequencing - Human PLA2G12A (Phospholipase A2 XII) knockout HeLa cell lysate (AB263299)
  • Sanger seq

Unknown

Sanger Sequencing - Human PLA2G12A (Phospholipase A2 XII) knockout HeLa cell lysate (AB263299)

Homozygous : 10 bp deletion in exon1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon1.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263299-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human PLA2G12A knockout HeLa cell lysate", "number":"AB263299-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263299-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
PLA2G12A
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Phospholipase A2 XII also known as PLA2G12A is an enzyme that catalyzes the hydrolysis of the sn-2 acyl bond in glycerophospholipids liberating free fatty acids and lysophospholipids. It is part of the phospholipase A2 family but lacks conventional enzymatic activity seen in other members. PLA2G12A has a molecular mass of approximately 19 kDa. This enzyme is secreted and expressed in various tissues including the pancreas and macrophages suggesting roles in different physiological contexts.
Biological function summary

The enzyme belongs to the large group of secreted phospholipases A2 that contribute to diverse biological processes despite its low catalytic activity. It does not form part of a complex but often interacts with other molecules during lipid metabolism. Also it participates in lipid mediator production which impacts inflammation and host defense mechanisms. Its presence in immune cells indicates a potential involvement in immune responses and tissue homeostasis.

Pathways

PLA2G12A is essential in the arachidonic acid metabolism pathway and inflammatory signaling pathways. It connects with other proteins such as secretory phospholipase A2 and cytosolic phospholipase A2. The enzyme's action leads to the release of lipid mediators that modulate inflammatory pathways highlighting its regulatory role in these networks. It influences the balance and interplay between the production and degradation of lipid mediators important for biological signaling.

Research points to PLA2G12A's involvement in inflammatory diseases and metabolic disorders. In conditions like arthritis elevated levels of PLA2G12A have been observed linking it to exacerbation of inflammation. Another connected protein cytosolic phospholipase A2 also has associations with inflammatory diseases and amplifies the role of PLA2G12A in inflammation. Understanding its function may provide further insights into therapeutic targets for reducing inflammation in such disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com